Maurizio Fava, MD

Original Research

Bereavement and the Diagnosis of Major Depressive Episode in the National Epidemiologic Survey on Alcohol and Related Conditions

August 23, 2011

Stephen E. Gilman, Joshua Breslau, Nhi-Ha Trinh, et al

ASCP Corner

Assessing the Adequacy of Past Antidepressant Trials: A Clinician's Guide to the Antidepressant Treatment Response Questionnaire

August 15, 2011

Martin Desseilles, Janet Witte, Trina E. Chang, et al

Educational Activity

Evidence for the Use of <span style="font-variant:small-caps;">l</span>-Methylfolate Combined With Antidepressants in MDD

August 15, 2011

Maurizio Fava, Richard C. Shelton, John M. Zajecka

Original Research

Concise Associated Symptoms Tracking Scale: A Brief Self-Report and Clinician Rating of Symptoms Associated With Suicidality

June 15, 2011

Madhukar H. Trivedi, Stephen R. Wisniewski, David W. Morris, et al

Original Research

Concise Health Risk Tracking Scale: A Brief Self-Report and Clinician Rating of Suicidal Risk

June 15, 2011

Madhukar H. Trivedi, Stephen R. Wisniewski, David W. Morris, et al

Original Research

Response Rates to Fluoxetine in Subjects Who Initially Show No Improvement

May 31, 2011

Michael A. Posternak, Lee Baer, Andrew A. Nierenberg, et al

Article

Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Studies

January 13, 2011

The objective of this study was to investigate the specific effect of adjunctive aripiprazole on sexual functionin patients with major depressive disorder and a history of an inadequate response...

Maurizio Fava, Christina M. Dording, Ross A. Baker, et al

Original Research

Improved Insomnia Symptoms and Sleep-Related Next-Day Functioning in Patients With Comorbid Major Depressive Disorder and Insomnia Following Concomitant Zolpidem Extended-Release 12.5 mg and Escitalopram Treatment: A Randomized Controlled Trial

December 28, 2010

Maurizio Fava, Gregory M. Asnis, Ram K. Shrivastava, et al

Educational Activity

Evidence for Folate in Combination With Antidepressants at Initiation of Therapy

November 15, 2010

Maurizio Fava, David Mischoulon

Article

Placebo-Controlled, Antidepressant Clinical Trials Cannot Be Shortened to Less Than 4 Weeks' Duration: A Pooled Analysis of Randomized Clinical Trials Employing a Diagnostic Odds Ratio-Based Approach

November 2, 2010

Enrico Tedeschini, Maurizio Fava, George I. Papakostas

Original Research

A Post Hoc Analysis of the Effect of Nightly Administration of Eszopiclone and a Selective Serotonin Reuptake Inhibitor in Patients With Insomnia and Anxious Depression

November 2, 2010

Maurizio Fava, Kendyl Schaefer, Holly Huang, et al

Educational Activity

Using Complementary and Alternative Medicines for Depression

September 15, 2010

Maurizio Fava

Bereavement and the Diagnosis of Major Depressive Episode in the National Epidemiologic Survey on Alcohol and Related Conditions

Assessing the Adequacy of Past Antidepressant Trials: A Clinician's Guide to the Antidepressant Treatment Response Questionnaire

Evidence for the Use of <span style="font-variant:small-caps;">l</span>-Methylfolate Combined With Antidepressants in MDD

Concise Associated Symptoms Tracking Scale: A Brief Self-Report and Clinician Rating of Symptoms Associated With Suicidality

Concise Health Risk Tracking Scale: A Brief Self-Report and Clinician Rating of Suicidal Risk

Response Rates to Fluoxetine in Subjects Who Initially Show No Improvement

Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Studies

Improved Insomnia Symptoms and Sleep-Related Next-Day Functioning in Patients With Comorbid Major Depressive Disorder and Insomnia Following Concomitant Zolpidem Extended-Release 12.5 mg and Escitalopram Treatment: A Randomized Controlled Trial

Evidence for Folate in Combination With Antidepressants at Initiation of Therapy

Placebo-Controlled, Antidepressant Clinical Trials Cannot Be Shortened to Less Than 4 Weeks' Duration: A Pooled Analysis of Randomized Clinical Trials Employing a Diagnostic Odds Ratio-Based Approach

A Post Hoc Analysis of the Effect of Nightly Administration of Eszopiclone and a Selective Serotonin Reuptake Inhibitor in Patients With Insomnia and Anxious Depression

Using Complementary and Alternative Medicines for Depression

ELSEWHERE:

FOLLOW US:

Maurizio Fava, MD

Bereavement and the Diagnosis of Major Depressive Episode in the National Epidemiologic Survey on Alcohol and Related Conditions

Assessing the Adequacy of Past Antidepressant Trials: A Clinician's Guide to the Antidepressant Treatment Response Questionnaire

Evidence for the Use of <span style="font-variant:small-caps;">l</span>-Methylfolate Combined With Antidepressants in MDD

Concise Associated Symptoms Tracking Scale: A Brief Self-Report and Clinician Rating of Symptoms Associated With Suicidality

Concise Health Risk Tracking Scale: A Brief Self-Report and Clinician Rating of Suicidal Risk

Response Rates to Fluoxetine in Subjects Who Initially Show No Improvement

Effects of Adjunctive Aripiprazole on Sexual Functioning in Patients With Major Depressive Disorder and an Inadequate Response to Standard Antidepressant Monotherapy: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Studies

Improved Insomnia Symptoms and Sleep-Related Next-Day Functioning in Patients With Comorbid Major Depressive Disorder and Insomnia Following Concomitant Zolpidem Extended-Release 12.5 mg and Escitalopram Treatment: A Randomized Controlled Trial

Evidence for Folate in Combination With Antidepressants at Initiation of Therapy

Placebo-Controlled, Antidepressant Clinical Trials Cannot Be Shortened to Less Than 4 Weeks' Duration: A Pooled Analysis of Randomized Clinical Trials Employing a Diagnostic Odds Ratio-Based Approach

A Post Hoc Analysis of the Effect of Nightly Administration of Eszopiclone and a Selective Serotonin Reuptake Inhibitor in Patients With Insomnia and Anxious Depression

Using Complementary and Alternative Medicines for Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles